-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Oruka Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Oruka Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$29.4M, a 1420% decline year-over-year.
- Oruka Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$36.6M, a 405% decline year-over-year.
- Oruka Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$7.3M, a 31.1% increase from 2022.
- Oruka Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$10.6M, a 45.2% increase from 2021.
- Oruka Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$19.3M, a 98% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)